請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/53206
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 曾宇鳳(Yufeng Jane Tseng) | |
dc.contributor.author | Tien-Chueh Kuo | en |
dc.contributor.author | 郭天爵 | zh_TW |
dc.date.accessioned | 2021-06-15T16:50:56Z | - |
dc.date.available | 2020-08-10 | |
dc.date.copyright | 2015-08-10 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-08-07 | |
dc.identifier.citation | 1. Hiraga, T., et al., Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. Cancer Research, 2007. 67(9): p. 4157-4163.
2. Semenza, G.L., Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 29(5): p. 625-634. 3. Zhong, H., et al., Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Research, 1999. 59(22): p. 5830-5835. 4. Erb, G., et al., Toward improved grading of malignancy in oligodendrogliomas using metabolomics. Magnetic Resonance in Medicine, 2008. 59(5): p. 959-965. 5. Chan, E.C.Y., et al., Metabolic Profiling of Human Colorectal Cancer Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Gas Chromatography Mass Spectrometry (GC/MS). Journal of Proteome Research, 2009. 8(1): p. 352-361. 6. Lundgren, K., C. Holm, and G. Landberg, Hypoxia and breast cancer: prognostic and therapeutic implications. Cellular and Molecular Life Sciences, 2007. 64(24): p. 3233-3247. 7. Tennant, D.A., et al., Metabolic transformation in cancer. Carcinogenesis, 2009. 30(8): p. 1269-1280. 8. Brizel, D.M., et al., Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Research, 1996. 56(5): p. 941-943. 9. Raghunand, N., R.A. Gatenby, and R.J. Gillies, Microenvironmental and cellular consequences of altered blood flow in tumours. British Journal of Radiology, 2003. 76: p. S11-S22. 10. Fulda, S. and K.M. Debatin, HIF-1-regulated glucose metabolism a key to apoptosis resistance? Cell Cycle, 2007. 6(7): p. 790-792. 11. Weidner, N., et al., Tumor angiogenesis and metastasis-correlation in invasive breast-carcinoma. New England Journal of Medicine, 1991. 324(1): p. 1-8. 12. Galanis, A., et al., Reactive oxygen species and HIF-1 signalling in cancer. Cancer Letters, 2008. 266(1): p. 12-20. 13. Brahimi-Horn, C., E. Berra, and J. Pouyssegur, Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends in Cell Biology, 2001. 11(11): p. S32-S36. 14. Keith, B., R.S. Johnson, and M.C. Simon, HIF1 alpha and HIF2 alpha: sibling rivalry in hypoxic tumour growth and progression. Nature Reviews Cancer, 2012. 12(1): p. 9-22. 15. Nicholson, J.K., Global systems biology, personalized medicine and molecular epidemiology. Molecular Systems Biology, 2006. 2: p. 52. 16. Lenz, E.M., et al., Metabonomics with H-1-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers, 2005. 10(2-3): p. 173-187. 17. Hara, T., A. Bansal, and T.R. DeGrado, Effect of hypoxia on the uptake of [methyl-H-3]choline, [1-C-14] acetate and [F-18]FDG in cultured prostate cancer cells. Nuclear Medicine and Biology, 2006. 33(8): p. 977-984. 18. Glunde, K., et al., Hypoxia regulates choline kinase expression through hypoxia-inducible factor-lot signaling in a human prostate cancer model. Cancer Research, 2008. 68(1): p. 172-180. 19. Yoshii, Y., et al., Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism. Cancer Science, 2009. 100(5): p. 821-827. 20. Richardson, A.D., et al., Central carbon metabolism in the progression of mammary carcinoma. Breast Cancer Research and Treatment, 2008. 110(2): p. 297-307. 21. Morse, D.L., et al., Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR in Biomedicine, 2009. 22(1): p. 114-127. 22. Weljie, A.M., et al., H-1 NMR metabolomics identification of markers of hypoxia-induced metabolic shifts in a breast cancer model system. Journal of Biomolecular NMR, 2011. 49(3-4): p. 185-193. 23. Troy, H., et al., Metabolic profiling of hypoxia-inducible factor-1 beta-deficient and wild type Hepa-1 cells: effects of hypoxia measured by H-1 magnetic resonance spectroscopy. Metabolomics, 2005. 1(4): p. 293-303. 24. Zhu, J., et al., Stitching together Multiple Data Dimensions Reveals Interacting Metabolomic and Transcriptomic Networks That Modulate Cell Regulation. PLoS Biology, 2012. 10(4). 25. Jain, M., et al., Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation. Science, 2012. 336(6084): p. 1040-1044. 26. Mahadevan, S., et al., Analysis of Metabolomic Data Using Support Vector Machines. Analytical Chemistry, 2008. 80(19): p. 7562-7570. 27. R Development Core Team, A Language and Environment for Statistical Computing. 2009. 28. Chang, C. and C. Lin, LIBSVM: a Library for Support Vector Machines, 2001. 29. Bando, H., et al., Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231. Biomedicine and Pharmacotherapy, 2003. 57(8): p. 333-340. 30. Kanehisa, M., et al., KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Research, 2010. 38(Database issue): p. D355-D360. 31. Shannon, P., et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research, 2003. 13(11): p. 2498-2504. 32. Greco, O., et al., How to overcome (and exploit) tumor hypoxia for targeted gene therapy. Journal of Cellular Physiology, 2003. 197(3): p. 312-325. 33. Graeber, T.G., et al., Hypoxia induces accumulation of P53 protein, but activation of a G(1)-phase checkpoint by low-oxygen conditions is independent of P53 status. Molecular and Cellular Biology, 1994. 14(9): p. 6264-6277. 34. Koong, A.C., E.Y. Chen, and A.J. Giaccia, Hypoxia causes the activation of nuclear factor kappa-B through the phosphorylation of I-kappa-B-alpha on tyrosine residues. Cancer Research, 1994. 54(6): p. 1425-1430. 35. Semenza, G.L. and G.L. Wang, A nuclear factor induced by hypoxia via denovo protein-synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Molecular and Cellular Biology, 1992. 12(12): p. 5447-5454. 36. Freitas, I., et al., Insitu lactate-dehydrogenase patterns as markers of tumor oxygenation. Anticancer Research, 1991. 11(3): p. 1293-1299. 37. Semenza, G.L., et al., Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. Journal of Biological Chemistry, 1996. 271(51): p. 32529-32537. 38. Semenza, G.L., et al., Transcriptional regulation of genes encoding glycolytic-enzymes by hypoxia-inducible factor-1. Journal of Biological Chemistry, 1994. 269(38): p. 23757-23763. 39. Firth, J.D., et al., Oxygen-regulated control elements in the phosphoglycerate kinase-1 and lactate-dehydrogenase-A genes-similarities with the erythropoietin 3' enhancer. Proceedings of the National Academy of Sciences of the United States of America, 1994. 91(14): p. 6496-6500. 40. Sivitz, W.I., et al., Pretranslational regulation of 2 cardiac glucose transporters in rats exposed to hypobaric hypoxia. American Journal of Physiology, 1992. 263(3): p. E562-E569. 41. Mathupala, S.P., A. Rempel, and P.L. Pedersen, Aberrant glycolytic metabolism of cancer cells: A remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for Type II hexokinase. Journal of Bioenergetics and Biomembranes, 1997. 29(4): p. 339-343. 42. Minchenko, A., et al., Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene - Its possible role in the Warburg effect. Journal of Biological Chemistry, 2002. 277(8): p. 6183-6187. 43. Airley, R., et al., Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clinical Cancer Research, 2001. 7(4): p. 928-934. 44. Chen, C.H., et al., Regulation of glut1 mRNA by hypoxia-inducible factor-1 - Interaction between H-ras and hypoxia. Journal of Biological Chemistry, 2001. 276(12): p. 9519-9525. 45. Kolev, Y., et al., Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: Association with hypoxia-inducible factor (HIF-1 alpha) pathway, angiogenic factors production and poor prognosis. Annals of Surgical Oncology, 2008. 15(8): p. 2336-2344. 46. Robey, I.F., et al., Hypoxia-inducible factor-1 alpha and the glycolytic phenotype in tumors. Neoplasia, 2005. 7(4): p. 324-330. 47. Shiu, R.P., P.H. Watson, and D. Dubik, C-myc oncognen expression in estrogen-dependent and estrogen-independent breast-cancer. Clinical Chemistry, 1993. 39(2): p. 353-355. 48. Wise, D.R., et al., Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences of the United States of America, 2008. 105(48): p. 18782-18787. 49. Soh, H., M. Wasa, and M. Fukuzawa, Hypoxia upregulates amino acid transport in a human neuroblastoma cell line. Journal of Pediatric Surgery, 2007. 42(4): p. 608-612. 50. Yoshii, Y., et al., Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET. Nuclear Medicine and Biology, 2009. 36(7): p. 771-777. 51. Loffler, M. and F. Schneider, Lipogenesis in ehrlich ascites tumor-cells under anaerobic culture conditions. Journal of Cancer Research and Clinical Oncology, 1979. 95(2): p. 115-122. 52. Vavere, A.L., et al., 1-C-11-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. Journal of Nuclear Medicine, 2008. 49(2): p. 327-334. 53. Furuta, E., et al., Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Research, 2008. 68(4): p. 1003-1011. 54. Southam, A.D., et al., Metabolic Changes in Flatfish Hepatic Tumours Revealed by NMR-Based Metabolomics and Metabolic Correlation Networks. Journal of Proteome Research, 2008. 7(12): p. 5277-5285. 55. Israel, M. and L. Schwartz, The metabolic advantage of tumor cells. Molecular Cancer, 2011. 10. 56. Rofstad, E.K., et al., P-31 nuclear magnetic-resonance spectroscopy studies of tumor energy-metabolism and its relationship to intracapillary oxyhemoglobin saturation status and tumor hypoxia. Cancer Research, 1988. 48(19): p. 5440-5446. 57. Griffin, J.L. and J.P. Shockcor, Metabolic profiles of cancer cells. Nature Reviews Cancer, 2004. 4(7): p. 551-561. 58. El-Sayed, S., et al., An ex vivo study exploring the diagnostic potential of H-1 magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 2002. 24(8): p. 766-772. 59. Moreno, A., et al., H-1 MRS markers of tumour growth in intrasplenic tumour and liver metastasis induced by injection of HT-29 cells in nude mice spleen. NMR in Biomedicine, 1998. 11(3): p. 93-106. 60. Schaffer, S.W., et al., Effect of ischemia, calcium depletion and repletion, acidosis and hypoxia on cellular taurine content. Amino Acids, 2002. 23(4): p. 395-400. 61. Gatenby, R.A., et al., Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. British Journal of Cancer, 2007. 97(5): p. 646-653. 62. Beckonert, O., et al., Visualizing metabolic changes in breast-cancer tissue using H-1-NMR spectroscopy and self-organizing maps. NMR in Biomedicine, 2003. 16(1): p. 1-11. 63. Kanehisa, M., et al., The KEGG resource for deciphering the genome. Nucleic Acids Research, 2004. 32(Database issue): p. D277-D280. 64. Dennis, G., Jr., et al., DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biology, 2003. 4(5): p. P3. 65. Christofk, H.R., et al., The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature, 2008. 452(7184): p. 230-233. 66. Nicholson, J.K. and I.D. Wilson, Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism. Nature Reviews Drug Discovery, 2003. 2(8): p. 668-676. 67. Kolbe, A., et al., Combined transcript and metabolite profiling of Arabidopsis leaves reveals fundamental effects of the thiol-disulfide status on plant metabolism. Plant Physiology, 2006. 141(2): p. 412-422. 68. Cho, K., et al., Integrated transcriptomics, proteomics, and metabolomics analyses to survey ozone responses in the leaves of rice seedling. Journal of Proteome Research, 2008. 7(7): p. 2980-2998. 69. Heijne, W.H., et al., Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology. Expert Review of Proteomics, 2005. 2(5): p. 767-780. 70. Ferrara, C.T., et al., Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genetics, 2008. 4(3): p. e1000034. 71. Carrari, F., et al., Integrated analysis of metabolite and transcript levels reveals the metabolic shifts that underlie tomato fruit development and highlight regulatory aspects of metabolic network behavior. Plant Physiology, 2006. 142(4): p. 1380-1396. 72. Xu, E.Y., et al., Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants. Chemical Research in Toxicology, 2008. 21(8): p. 1548-1561. 73. Nam, H., et al., Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics, 2009. 25(23): p. 3151-3157. 74. Su, G., et al., Integrated metabolome and transcriptome analysis of the NCI60 dataset. BMC Bioinformatics, 2011. 12 Suppl 1: p. S36. 75. Gehlenborg, N., et al., Visualization of omics data for systems biology. Nataure Methods, 2010. 7(3 Suppl): p. S56-S68. 76. Junker, B.H., C. Klukas, and F. Schreiber, VANTED: a system for advanced data analysis and visualization in the context of biological networks. BMC Bioinformatics, 2006. 7: p. 109. 77. Hu, Z., et al., VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology. Nucleic Acids Research, 2009. 37(Web Server issue): p. W115-W121. 78. Karnovsky, A., et al., Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics, 2012. 28(3): p. 373-380. 79. Pavlopoulos, G., et al., Arena3D: visualization of biological networks in 3D. BMC Systems Biology, 2008. 2(1): p. 104. 80. McGuffin, M.J. and I. Jurisica, Interaction techniques for selecting and manipulating subgraphs in network visualizations. IEEE Transactions on Visualization and Computer Graphics, 2009. 15(6): p. 937-944. 81. Barsky, A., et al., Cerebral: visualizing multiple experimental conditions on a graph with biological context. IEEE Transactions on Visualization and Computer Graphics, 2008. 14(6): p. 1253-1260. 82. Bader, G.D., M.P. Cary, and C. Sander, Pathguide: a pathway resource list. Nucleic Acids Research, 2006. 34(Database issue): p. D504-D506. 83. Arakawa, K., et al., KEGG-based pathway visualization tool for complex omics data. In Silico Biology, 2005. 5(4): p. 419-423. 84. Kanehisa, M. and S. Goto, KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Research, 2000. 28(1): p. 27-30. 85. Garcia-Alcalde, F., et al., Paintomics: a web based tool for the joint visualization of transcriptomics and metabolomics data. Bioinformatics, 2011. 27(1): p. 137-139. 86. Neuweger, H., et al., Visualizing post genomics data-sets on customized pathway maps by ProMeTra-aeration-dependent gene expression and metabolism of Corynebacterium glutamicum as an example. BMC Systems Biology, 2009. 3: p. 82. 87. Tokimatsu, T., et al., KaPPA-view: a web-based analysis tool for integration of transcript and metabolite data on plant metabolic pathway maps. Plant Physiology, 2005. 138(3): p. 1289-1300. 88. Thimm, O., et al., MAPMAN: a user-driven tool to display genomics data sets onto diagrams of metabolic pathways and other biological processes. The Plant Journal, 2004. 37(6): p. 914-939. 89. Symons, S., et al., Integrative systems biology visualization with MAYDAY. Journal of Integrative Bioinformatics, 2010. 7(3). 90. Ludemann, A., et al., PaVESy: Pathway Visualization and Editing System. Bioinformatics, 2004. 20(16): p. 2841-2844. 91. Ingenuity Pathways Analysis software. 92. Hoffmann, R. and A. Valencia, A gene network for navigating the literature. Nature Genetics, 2004. 36(7): p. 664. 93. iHOP [http://www.ihop-net.org/]. 94. Romero, P., et al., Computational prediction of human metabolic pathways from the complete human genome. Genome Biology, 2004. 6(1): p. R2. 95. Huang da, W., B.T. Sherman, and R.A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocol, 2009. 4(1): p. 44-57. 96. Maglott, D., et al., Entrez Gene: gene-centered information at NCBI. Nucleic Acids Research, 2011. 39(Database issue): p. D52-D57. 97. Apweiler, R., et al., UniProt: the Universal Protein knowledgebase. Nucleic Acids Research, 2004. 32(Database issue): p. D115-D119. 98. Wang, Y., et al., PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Research, 2009. 37(suppl 2): p. W623-W633. 99. R Development Core Team, R: A Language and Environment for Statistical Computing. 2010, Vienna, Austria. 100. Bolker and Greg. R.W., et al., gplots: Various R programming tools for plotting data. 2010. 101. Zhang, H. and Y. Yang, An algorithm for thorough background subtraction from high-resolution LC/MS data: application for detection of glutathione-trapped reactive metabolites. Journal of Mass Spectrometry, 2008. 43(9): p. 1181-1190. 102. Google Chart Tools [https://developers.google.com/chart/]. 103. Zheng, P.-Z., et al., Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 2005. 102(21): p. 7653-7658. 104. Xia, J. and D.S. Wishart, MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics, 2010. 26(18): p. 2342-2344. 105. Rivera, O.J., et al., Role of the Promyelocytic Leukemia Body in the Dynamic Interaction between the Androgen Receptor and Steroid Receptor Coactivator-1 in Living Cells. Molecular Endocrinology, 2003. 17(1): p. 128-140. 106. Ueda, T., et al., Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer Cells. Journal of Biological Chemistry, 2002. 277(41): p. 38087-38094. 107. Agoulnik, I.U., et al., Role of SRC-1 in the Promotion of Prostate Cancer Cell Growth and Tumor Progression. Cancer Research, 2005. 65(17): p. 7959-7967. 108. Harris, M.N., et al., Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood, 2004. 104(5): p. 1314-1323. 109. Ishii, N., et al., Multiple High-Throughput Analyses Monitor the Response of E. coli to Perturbations. Science, 2007. 316(5824): p. 593-597. 110. Trauger, S.A., et al., Correlating the Transcriptome, Proteome, and Metabolome in the Environmental Adaptation of a Hyperthermophile. Journal of Proteome Research, 2008. 7(3): p. 1027-1035. 111. Watson, A.D., Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Lipidomics: a global approach to lipid analysis in biological systems. Journal of Lipid Research, 2006. 47(10): p. 2101-2111. 112. Benakanakere, I., et al., Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells. Experimental Hematology & Oncology, 2014. 3(1): p. 24. 113. Bradley, E., et al., Critical Role of Spns2, a Sphingosine-1-Phosphate Transporter, in Lung Cancer Cell Survival and Migration. PLoS ONE, 2014. 9(10): p. e110119. 114. Cheng, H., et al., Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease: an early event in disease pathogenesis. Journal of Neurochemistry, 2013. 127(6): p. 733-738. 115. Wood, P., Lipidomics of Alzheimer's disease: current status. Alzheimer's Research & Therapy, 2012. 4(1): p. 5. 116. Kain, V., S. Prabhu, and G. Halade, Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Research in Cardiology, 2014. 109(6): p. 1-17. 117. Perez, O., et al., Breast cancer and obesity impact the lipid composition of breast adipose tissue: a preliminary study using shotgun lipidomics. Cancer Research, 2014. 74(19 Supplement): p. 3496. 118. Wood, P.L., et al., Lipidomics reveals dysfunctional glycosynapses in schizophrenia and the G72/G30 transgenic mouse. Schizophrenia Research, (0). 119. Zhou, X., et al., Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics. PLoS ONE, 2012. 7(11): p. e48889. 120. Wishart, D.S., et al., HMDB: the Human Metabolome Database. Nucleic Acids Research, 2007. 35(suppl 1): p. D521-D526. 121. Caffrey, M. and J. Hogan, LIPIDAT: A database of lipid phase transition temperatures and enthalpy changes. DMPC data subset analysis. Chemistry and physics of lipids, 1992. 61(1): p. 1-109. 122. Watanabe, K., E. Yasugi, and M. Oshima, How to search the glycolipid data in LIPIDBANK for Web: The newly developed lipid database. Japan Trend Glycoscience and Glycotechnology, 2000. 12: p. 175-184. 123. Sud, M., et al., LMSD: LIPID MAPS structure database. Nucleic Acids Research, 2007. 35(suppl 1): p. D527-D532. 124. Foster, J.M., et al., LipidHome: a database of theoretical lipids optimized for high throughput mass spectrometry lipidomics. PLoS ONE, 2013. 8(5): p. e61951. 125. Sud, M., et al., LMSD: lipid maps structure database. Nucleic Acids Research, 2007. 35(suppl 1): p. D527-D532. 126. Baldridge, J., The opennlp project. [http://opennlp.apache.org/index.html]. 127. Rindflesch, T.C. and M. Fiszman, The interaction of domain knowledge and linguistic structure in natural language processing: interpreting hypernymic propositions in biomedical text. Journal of Biomedical Informatics, 2003. 36(6): p. 462-477. 128. Bodenreider, O., The unified medical language system (UMLS): integrating biomedical terminology. Nucleic Acids Research, 2004. 32(suppl 1): p. D267-D270. 129. McCray, A.T. The UMLS semantic network. in Proc 13th Annu Symp Comput Appl Med Care. 1989. 130. Ashburner, M., et al., Gene Ontology: tool for the unification of biology. Nature genetics, 2000. 25(1): p. 25-29. 131. Supek, F., et al., REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE, 2011. 6(7): p. e21800. 132. National Center for Health Statistics, ICD-9-CM: International Classification of Diseases 9th Revision Clinical Modification. 1980: US Department of Health and Human Services, Public Health Service, Health Care Financing Administration. 133. Degtyarenko, K., et al., ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Research, 2008. 36(suppl 1): p. D344-D350. 134. Lipscomb, C.E., Medical subject headings (MeSH). Bulletin of the Medical Library Association, 2000. 88(3): p. 265. 135. Scherer, M., G. Schmitz, and G. Liebisch, High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. Clinical Chemistry, 2009. 55(6): p. 1218-1222. 136. Panchatcharam, M., et al., Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia. Arteriosclerosis, Thrombosis, and Vascular Biology, 2013. 33(1): p. 52-59. 137. Kuriyama, S., et al., In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity. Journal of Cell Biology, 2014. 206(1): p. 113-127. 138. Lin, F.T., et al., The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival. Journal of Biological Chemistry, 2007. 282(52): p. 37759-37769. 139. Baudhuin, L.M., et al., Akt Activation Induced by Lysophosphatidic Acid and Sphingosine-1-phosphate Requires Both Mitogen-Activated Protein Kinase Kinase and p38 Mitogen-Activated Protein Kinase and Is Cell-Line Specific. Molecular Pharmacology, 2002. 62(3): p. 660-671. 140. Hu, X., et al., Lysophosphatidic Acid (LPA) Protects Primary Chronic Lymphocytic Leukemia Cells from Apoptosis through LPA Receptor Activation of the Anti-apoptotic Protein AKT/PKB. Journal of Biological Chemistry, 2005. 280(10): p. 9498-9508. 141. Ren, B., et al., Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway. Blood, 2011. 117(22): p. 6036-6045. 142. Yoshioka, K., et al., Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J Biol Chem, 1998. 273(9): p. 5146-5154. 143. Geach, T.J., et al., An essential role for LPA signalling in telencephalon development. Development, 2014. 141(4): p. 940-949. 144. Kiss, G.N., et al., Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions. Molecular Pharmacology, 2012. 82(6): p. 1162-1173. 145. Li, H., et al., Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice. Molecular Cancer Therapeutics, 2009. 8(6): p. 1692-1701. 146. Su, S.C., et al., Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma. Clinical Cancer Research, 2013. 19(23): p. 6461-6472. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/53206 | - |
dc.description.abstract | 藉由腫瘤缺氧代謝體分析確認過往由轉錄體分析所得到認知,透過整合轉錄體與代謝體可擴展現有知識。藉由整合跨體學分析,瞭解整合性分析軟體需要廣泛相關工具知識與背景知識,因此開發了系統生物學工具3Omics讓使用者可快速進行整合性分析。完成整合性分析後,為了解決生物詮釋遇到的問題,開發了脂質百科以加速耗費大量人力閱讀文獻過程,提供脂質之生醫相關資訊。
目前針對腫瘤缺氧整體性分析仍然侷限於單一體學,以系統生物學結合多個體學資料能增進我們對生物系統的知識。因此我們以代謝體與文獻中轉錄體探討時序性變化,以提供生物系統應對腫瘤缺氧之系統層面視角。從代謝體分析、轉錄體學與代謝體學代謝途徑分析結果確認了過往轉錄體學認知,擴展現有腫瘤缺氧已知模型上的知識,同時也呈現了整合性分析效果。 藉由整合腫瘤缺氧狀況下之轉錄體與代謝體,顯示整合性分析需要相當廣泛的工具與相關知識及許多背景觀念。因此我們開發系統生物學工具3Omics,藉由提供五種常用分析,快速整合三種人類轉錄體、蛋白體學、代謝體學資料,進行跨體學整合、或單一體學內分析。當使用者輸入三種中兩種資料,3Omics會以文字探勘PubMed資料庫方式以補充未提供之資料。3Omics簡化整合分析流程,讓使用者可執行一鍵式整合分析。 研究者完成整合性系統生物學分析後,接著步驟則是生物學詮釋。為解釋生物學詮釋目前所遇到的問題,以脂質體分析作為範例。從單一實驗中即可偵測出上百種脂質表現與變化。因同一種脂質類別內之脂質具有高度化學結構以及名稱相似性,使得研究者難以了解所偵測得之脂質功能或相關疾病。因此研究者需要以脂質名稱搜尋並閱讀相關文獻,才能找出相關知識。為了加速此耗費大量人力閱讀文獻過程,我們藉由基於UMLS系統開發脂質百科,使用文字探勘期刊文獻,獲取並提供脂質之生醫相關資訊。 | zh_TW |
dc.description.abstract | The majority of researches of tumor hypoxia have been limited to just single omics level. Combining multiple omics data by systems biology approaches can improve our knowledge in biological systems. Here, we investigated the temporal changes of the metabolome with transcriptome from literature to provide a more comprehensive insight on the system level in response to hypoxia. Pathway analysis of metabolomic and transcriptomic data confirm understandings from previous transcriptomic analyses and expand the knowledge from existing models between transcriptome and metabolome of tumor hypoxia demonstrating the power of integrated omics analysis.
Through integrating omics data of tumor hypoxia, it is known that integrating multiple omics data requires an intensive knowledge of tools and background concepts. 3Omics was developed to rapidly integrate multiple human inter- or intra-transcriptomic, proteomic, and metabolomic data by combining commonly used analyses. If only two of three omics datasets are input, 3Omics supplements the missing transcript, protein or metabolite information related to the input by text-mining PubMed database. 3Omics simplifies data analysis and enabling users to perform a one-click integrated analysis. After researchers finished the integrated analyses of systems biology, the next step is the biological interpretation. To explain the problem of biological interpretation, lipidomics analyses are used as an example. Hundreds of lipid species can be detected in a single experiment. It is hard to know the associated functions or diseases of each lipid in the lipidomics studies for the highly similar name and chemical structure of each lipid class. Researchers need to find and read associated references from searching names of the lipid. To accelerate the labor-intensive process of reading references, we developed LipidPedia for providing associated biomedical information by using text-mining strategy in literatures based on UMLS. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T16:50:56Z (GMT). No. of bitstreams: 1 ntu-104-D97945015-1.pdf: 3956030 bytes, checksum: f2bb0afb3b7fed62890227abd40be13f (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 致謝 i
中文摘要 ii Abstract iii 1. Metabolomic changes in MDA-MB-231 cell under hypoxia 1 1.1. Introduction 1 1.2. Materials and methods 4 1.2.1 Cell culture and hypoxia treatment 4 1.2.2 Extraction of intra-cellular metabolite 4 1.2.3 Sample preparation for 1H NMR spectroscopy 4 1.2.4 Metabolome analysis 5 1.2.5 Data analysis 6 1.3. Results and discussions 8 1.3.1 NMR metabolic profiles 8 1.3.2 Influence of hypoxia on metabolic profiles of MDA-MB-231 cancer cells 9 1.3.3 Inference of metabolic pathway network from transcriptome and metabolome 22 1.4. Conclusion 29 2. 3Omics: A web-based systems biology tool for human transcriptomics, proteomics and metabolomics 30 2.1 Introduction of 3Omics 30 2.1.1 Current tools for integrating omics data 30 2.1.2 Comparison of 3Omics with other software 31 2.2 Implementation 33 2.2.1 System Overview 33 2.2.2 Summary of 3Omics features 35 2.2.3 Correlation analysis 40 2.2.4 Coexpression analysis 41 2.2.5 Phenotype analysis 42 2.2.6 Pathway enrichment analysis 42 2.2.7 Gene ontology-based enrichment analysis 43 2.3 Results and discussions 44 Case studies 44 2.4 Limitation 55 2.5 Conclusion 55 3. LipidPedia 57 3.1 Introduction 57 3.2 Materials and methods 58 3.2.1 Designed sections of LipidPedia 58 3.2.2 Lipid species list retrieval 58 3.2.3 Relevant reference retrieval of lipids 58 3.2.4 Preprocessing of retrieved text, named entity recognition and UMLS mapping 59 3.2.5 Collection of biological information associated with lipids 59 3.2.6 Implementation of LipidPedia 59 3.3 Results 65 3.3.1 Lipid species list retrieval 65 3.3.2 Relevant reference retrieval 65 3.3.3 Named entity recognition and information extraction 66 3.3.4 Collection of biomedical information associated with the lipids 66 3.3.5 Biomedical information organization 71 3.3.6 Construction of database and web application 71 3.4 Discussion 73 Case studies: Lysophosphatidic acid 18:1 (LPA 18:1) 73 Introduction of Lysophosphatidic acid (18:1) 73 Diseases related to LPA (18:1) 73 Genes/proteins related to LPA (18:1) 74 Locations related to LPA (18:1) 78 Associated pathways of LPA (18:1) 79 Functions related to LPA (18:1) 81 Lipids related to LPA (18:1) 83 Common seen animal and experimental models related to LPA (18:1) 85 3.5 Conclusion 87 4. References 88 Curriculum Vitae 104 | |
dc.language.iso | en | |
dc.title | 代謝體系統生物學分析與工具及脂質知識庫 | zh_TW |
dc.title | Analysis and Tool of Metabolomics in Systems Biology and a Lipidomics Knowledgebase | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 徐麗芬,郭柏秀,郭錦樺,王國清 | |
dc.subject.keyword | 代謝體,生物資訊,系統生物學,脂質體,文字探勘, | zh_TW |
dc.subject.keyword | metabolomics,bioinformatics,systems biology,lipidomics,text mining, | en |
dc.relation.page | 105 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-08-07 | |
dc.contributor.author-college | 電機資訊學院 | zh_TW |
dc.contributor.author-dept | 生醫電子與資訊學研究所 | zh_TW |
顯示於系所單位: | 生醫電子與資訊學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 3.86 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。